Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-012756
Filing Date
2023-11-21
Accepted
2023-11-21 21:38:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31847
2 filename2.txt TEXT-EXTRACT 8035
  Complete submission text file 0000000000-23-012756.txt   52667
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filed for) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 377-06910
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)